Last reviewed · How we verify

NCT07361614

Pilot Testing of a Colorectal Cancer Education Program

Not yet recruiting NA Last updated 23 January 2026
What this trial tests

NA trial testing Educational Program in Colorectal Cancer Screening in 50 participants. Not yet recruiting.

Timeline
30 January 2026
Primary endpoint
28 February 2027
31 August 2027

Quick facts

Lead sponsorNYU Langone Health
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment50
Start date30 January 2026
Primary completion28 February 2027
Estimated completion31 August 2027
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 45 to 75, any sex, with Colorectal Cancer Screening. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to assess the feasibility, acceptability, and preliminary efficacy of a culturally and linguistically targeted, colorectal cancer (CRC) education program to improve CRC screening completion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Educational Program

Trials testing the same drug.

Other recruiting trials for Colorectal Cancer Screening

Currently open trials in the same condition.

Other NYU Langone Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07361614.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing